ProCE Banner Activity

Expert Dermatologists Respond to Questions About JAK Inhibitor Therapy for Alopecia Areata

Clinical Thought

Read our responses to insightful audience questions from a recent webinar and on-demand series about the rapidly expanding treatment landscape for alopecia areata (AA).

Released: December 05, 2023

Share

Faculty

Brittany Craiglow

Brittany Craiglow, MD

Associate Adjunct Professor
Department of Dermatology
Yale School of Medicine
New Haven, Connecticut

Maryanne Makredes Senna

Maryanne Makredes Senna, MD, FAAD

Assistant Professor of Dermatology 
Harvard Medical School 
Boston, Massachusetts 
Director, Lahey Hair Loss Center of Excellence
Lahey Hospital and Medical Center 
Burlington, Massachusetts

Provided by

Provided by Clinical Care Options, LLC in partnership with the National Alopecia Areata Foundation.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

National Alopecia Areata Foundation

ProCE Banner

Target Audience

The intended target audience for this program is US dermatologists and NP/PAs who treat patients with AA.

Program Learning Goal

The goal of this program is for learners to demonstrate and improve their application of knowledge, clinical performance, and confidence in making treatment decisions to optimize the treatment of patients with AA.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Formulate an accurate diagnosis and classification of AA based on multiple disease and patient factors

  • Detail factors that may predict a patient’s positive or negative response to JAK inhibitor therapy for AA

  • Evaluate patients with AA for treatment candidacy with JAK inhibitor therapy

Disclosure

Program Director

Brittany Craiglow, MD

Associate Adjunct Professor
Department of Dermatology
Yale School of Medicine
New Haven, Connecticut

Brittany Craiglow, MD: consultant/advisor/speaker: AbbVie, Concert Pharmaceuticals, Incyte, Lilly, Pfizer, Regeneron, Sanofi-Genzyme.

Maryanne Makredes Senna, MD, FAAD

Assistant Professor of Dermatology 
Harvard Medical School 
Boston, Massachusetts 
Director, Lahey Hair Loss Center of Excellence
Lahey Hospital and Medical Center 
Burlington, Massachusetts

Maryanne Makredes Senna, MD, FAAD: consultant/advisor/speaker: AbbVie, Kintor, L’Oréal, Lilly, Pfizer, Inmagene.